Switzerland · Research startup
Switzerland · Cardiorentis AG
Cardiorentis is a biopharmaceutical company designed for drug development.
Funding reportedLast round: Series B
What company datasets say Cardiorentis AG raised
Funding, as reported
Reported in all118.5Min the source's currency
Rounds2
Last roundSeries B
Last round size60M
Last round dateJan 2016
Investors listed1
The company, in detail
What they build
Known for
research services
Built with from their website
Microsoft Exchange OnlineMicrosoft ExchangeNginxMicrosoft 365OutlookMicrosoft 365 Apps & ServicesMicrosoft Email Providers
- Sector
- Research
- Region
- Canton of Zug
- Full record
- Every detail in the company directory
Research in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Cardiorentis AG in front of investors. Or tell us what we have wrong.